Bulletin
Investor Alert

Blueprint Medicines Corp.

NAS: BPMC

GO
/marketstate/country/us

After Hours

/zigman2/quotes/209215354/composite

$

100.93

Change

-0.06 -0.06%

Volume

Volume 3,233

Jan 15, 2021, 7:22 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209215354/composite

Previous close

$ 102.51

$ 100.99

Change

-1.52 -1.48%

Day low

Day high

$100.57

$103.00

Open
Open: 102.01

52 week low

52 week high

$43.29

$125.61

Open

Market cap

$5.63B

Average volume

510,563

P/E ratio

18.59

Rev. per Employee

$173,661

EPS

5.43

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bpmc

MarketWatch News on BPMC

  1. Blueprint Medicines started at hold with $110 stock price target at Stifel Nicolaus

    8:00 a.m. Dec. 3, 2020

    - Tomi Kilgore

  2. Here Are Stocks That Benefit Under Different Election Outcomes

    11:26 a.m. Oct. 20, 2020

    - Barron's Online

  3. The Pandemic Speeds Up the Health-Care Revolution

    5:01 p.m. Oct. 6, 2020

    - Barron's Online

  4. Blueprint Medicines shares gain on deal with Roche

    7:28 a.m. July 14, 2020

    - Jaimy Lee

  5. Roche, Blueprint to co-develop lung-cancer drug

    1:18 a.m. July 14, 2020

    - MarketWatch.com

  6. 7 Biotech Stocks to Buy for a Post-Pandemic World

    9:48 p.m. Aug. 17, 2020

    - Barron's Online

  7. Blueprint Medicines upgraded to outperform at BMO Capital

    7:37 a.m. March 17, 2020

    - Tomi Kilgore

  8. Blueprint Medicines upgraded to buy from hold at Deutsche Bank

    6:26 a.m. March 17, 2020

    - Tomi Kilgore

  9. Blueprint Medicines started at market perform at BMO Capital

    9:16 a.m. Jan. 28, 2020

    - Tomi Kilgore

  10. A Biotech Veteran Thinks He Can Undersell the Entire Drug Industry

    12:19 p.m. Jan. 12, 2020

    - Barron's Online

  11. Blueprint prices new cancer drug at $32,000 per month

    8:49 a.m. Jan. 10, 2020

    - Jaimy Lee

  12. Blueprint Medicines reiterated as buy at Canaccord

    2:02 p.m. Dec. 10, 2019

    - Ciara Linnane

  13. Blueprint Medicines upgraded to strong buy from outperform at Raymond James

    8:28 a.m. Nov. 6, 2019

    - Tomi Kilgore

  14. Blueprint Medicines started at buy with $110 stock price target at Deutsche Bank

    1:17 p.m. July 18, 2019

    - Tomi Kilgore

  15. Charting a bull-trend pullback, S&P 500 nails major support

    10:39 a.m. June 26, 2019

    - Michael Ashbaugh

  16. Blueprint Medicines started at overweight with $112 stock price target at Morgan Stanley

    8:44 a.m. April 3, 2019

    - Tomi Kilgore

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bpmc

Other News on BPMC

  1. Blueprint Medicines (BPMC) Received its Third Buy in a Row

    7:27 a.m. Jan. 12, 2021

    - SmarterAnalyst

  2. Blueprint Medicines announces leadership transitions

    12:24 p.m. Jan. 11, 2021

    - Seeking Alpha

  3. 3 Biotech Stocks Worth Adding to Your Portfolio in 2021

    9:05 a.m. Jan. 8, 2021

    - Zacks.com

  4. Amarin (AMRN) Surges: Stock Moves 9% Higher

    8:46 a.m. Dec. 31, 2020

    - Zacks.com

  5. Cogent Biosciences gets Piper Sandler nod on Kiq acquisition

    10:53 a.m. Dec. 23, 2020

    - Seeking Alpha

  6. A Director at Blueprint Medicines is Exercising Options

    11:01 p.m. Nov. 4, 2020

    - SmarterAnalyst

  7. Loading more headlines...
/news/pressrelease/company/us/bpmc

Press Releases on BPMC

  1. Blueprint Medicines Announces R&D Leadership Transitions

    8:05 a.m. Jan. 11, 2021

    - PR Newswire - PRF

  2. Blueprint Medicines Reports Third Quarter 2020 Financial Results

    7:00 a.m. Oct. 29, 2020

    - PR Newswire - PRF

  3. Blueprint Medicines Corp. to Host Earnings Call

    6:31 a.m. Oct. 29, 2020

    - ACCESSWIRE

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.